Circulating Vascular Endothelial Growth Factor (VEGF) Levels in Advanced Stage Cancer Patients Compared to Normal Controls and Diabetes Mellitus Patients with Critical Ischemia

Anti-angiogenic therapy is emerging as a valuable tool in the treatment of patients with cancer. As VEGF is a central target in anti-angiogenic therapy, its levels in the circulation might be relevant in selecting tumor types or patients likely to respond to this treatment. Additional VEGF has been...

Descripción completa

Detalles Bibliográficos
Autores principales: Kusumanto, Yoka H., Meijer, Coby, Dam, Wendy, Mulder, Nanno H., Hospers, Geke A.P.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Libertas Academica 2007
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3155238/
https://www.ncbi.nlm.nih.gov/pubmed/21901067

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3155238/
https://www.ncbi.nlm.nih.gov/pubmed/21901067

Ejemplares similares